Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Stern

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Oncogene|May 1, 1991
TPA inhibits the tyrosine kinase activity of the neu protein in vivo and in vitroH Cao, S Decker, D F Stern
Journal of Virology|April 1, 1982
Structural analysis of virion proteins of the avian coronavirus infectious bronchitis virusD F Stern, L Burgess, B M Sefton
Current Genetics|February 1, 1997
Mutations in SPK1/RAD53 that specifically abolish checkpoint but not growth-related functionsD S Fay, Z Sun, D F Stern
Molecular and Cellular Biology|September 1, 1988
Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivoD F Stern, M P Kamps, H Cao
Molecular and Cellular Biology|March 1, 1990
Tyrosine phosphorylation is an early and specific event involved in primary keratinocyte differentiationE Filvaroff, D F Stern, G P Dotto
Molecular and Cellular Biology|May 1, 1986
p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activityD F Stern, P A Heffernan, R A Weinberg
Current Protocols in Molecular Biology|February 12, 2008
Production of antibodies that recognize specific tyrosine-phosphorylated peptidesM P Digiovanna, R R Roussel, D F Stern
Science (New York, N.Y.)|July 10, 1998
Rad53 FHA domain associated with phosphorylated Rad9 in the DNA damage checkpointZ Sun, J Hsiao, D S Fay, et al.
The EMBO Journal|March 1, 1992
A subdomain in the transmembrane domain is necessary for p185neu* activationH Cao, L Bangalore, B J Bormann, et al.
Molecular and Cellular Biology|February 1, 1991
Spk1, a new kinase from Saccharomyces cerevisiae, phosphorylates proteins on serine, threonine, and tyrosineD F Stern, P Zheng, D R Beidler, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Oncogene|May 1, 1991
TPA inhibits the tyrosine kinase activity of the neu protein in vivo and in vitroH Cao, S Decker, D F Stern
Journal of Virology|April 1, 1982
Structural analysis of virion proteins of the avian coronavirus infectious bronchitis virusD F Stern, L Burgess, B M Sefton
Current Genetics|February 1, 1997
Mutations in SPK1/RAD53 that specifically abolish checkpoint but not growth-related functionsD S Fay, Z Sun, D F Stern
Molecular and Cellular Biology|September 1, 1988
Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivoD F Stern, M P Kamps, H Cao
Molecular and Cellular Biology|March 1, 1990
Tyrosine phosphorylation is an early and specific event involved in primary keratinocyte differentiationE Filvaroff, D F Stern, G P Dotto
Molecular and Cellular Biology|May 1, 1986
p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activityD F Stern, P A Heffernan, R A Weinberg
Current Protocols in Molecular Biology|February 12, 2008
Production of antibodies that recognize specific tyrosine-phosphorylated peptidesM P Digiovanna, R R Roussel, D F Stern
Science (New York, N.Y.)|July 10, 1998
Rad53 FHA domain associated with phosphorylated Rad9 in the DNA damage checkpointZ Sun, J Hsiao, D S Fay, et al.
The EMBO Journal|March 1, 1992
A subdomain in the transmembrane domain is necessary for p185neu* activationH Cao, L Bangalore, B J Bormann, et al.
Molecular and Cellular Biology|February 1, 1991
Spk1, a new kinase from Saccharomyces cerevisiae, phosphorylates proteins on serine, threonine, and tyrosineD F Stern, P Zheng, D R Beidler, et al.
Pageof 7